With an estimated 44 million diagnosed with Alzheimer’s disease worldwide, research is moving quickly to better understand the disease.
In this webinar, hear a caregiver explain the steps she took to support her dad after he was diagnosed with Alzheimer’s disease, gain insights into why it has been so hard to come up with better treatments for this challenging condition, and learn about ongoing efforts to develop novel therapeutic strategies to halt and prevent Alzheimer’s disease, as well as other forms of dementia.
This event was hosted with Kensington Place, a memory care residence that exclusively serves individuals with memory loss and their families.
Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
Gladstone scientists make headway toward new treatments for people with chronic long-term effects
Gladstone Experts Traumatic Brain Injury Neurological Disease Akassoglou Lab Paz Lab Srivastava LabImprovements in the cell analysis technique known as flow cytometry are helping Gladstone researchers make discoveries in immunology, stem cell biology, cardiology, and neuroscience
Gladstone Experts Flow Cytometry Core Neurological Disease Alexanian Lab Roan LabGladstone scientists answer questions about the convergence of COVID-19, RSV, and the flu this winter
Gladstone Experts COVID-19 Virology Greene Lab Ott Lab Roan Lab